Estimation of Radiobiologic Parameters and Equivalent Radiation Dose of Cytotoxic Chemotherapy in Malignant Glioma
Abstract
Purpose: To determine the radiobiologic parameters for highgrade gliomas. Methods and Materials: The biologic effective dose concept is used to estimate the {alpha}/{beta} ratio and K (dose equivalent for tumor repopulation/d) for highgrade glioma patients treated in a randomized fractionation trial. The equivalent radiation dose of temozolomide (Temodar) chemotherapy was estimated from another randomized study. The method assumes that the radiotherapy biologic effective dose is proportional to the adjusted radiotherapy survival duration of highgrade glioma patients. Results: The median tumor {alpha}/{beta} and K estimate is 9.32 Gy and 0.23 Gy/d, respectively. Using the published surviving fraction after 2Gy exposure (SF{sub 2}) data, and the above {alpha}/{beta} ratio, the estimated median {alpha} value was 0.077 Gy{sup 1}, {beta} was 0.009 Gy{sup 2}, and the cellular doubling time was 39.5 days. The median equivalent biologic effective dose of temozolomide was 11.03 Gy{sub 9.3} (equivalent to a radiation dose of 9.1 Gy given in 2Gy fractions). Random sampling trial simulations based on a cure threshold of 70 Gy in highgrade gliomas have shown the potential increase in tumor cure with dose escalation. Partial elimination of hypoxic cells (by chemical hypoxic cell sensitizers or carbon ion therapy) has suggested that considerable gains in tumormore »
 Authors:
 Birmingham Cancer Centre, University Hospital Birmingham, Birmingham (United Kingdom). Email: b.jones.1@bham.ac.uk
 Birmingham Cancer Centre, University Hospital Birmingham, Birmingham (United Kingdom)
 Publication Date:
 OSTI Identifier:
 20951663
 Resource Type:
 Journal Article
 Resource Relation:
 Journal Name: International Journal of Radiation Oncology, Biology and Physics; Journal Volume: 68; Journal Issue: 2; Other Information: DOI: 10.1016/j.ijrobp.2006.12.025; PII: S03603016(06)036509; Copyright (c) 2007 Elsevier Science B.V., Amsterdam, Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA)
 Country of Publication:
 United States
 Language:
 English
 Subject:
 62 RADIOLOGY AND NUCLEAR MEDICINE; CHEMOTHERAPY; CLINICAL TRIALS; DOSE EQUIVALENTS; FRACTIONATED IRRADIATION; GLIOMAS; PATIENTS; RADIATION DOSES; RADIOBIOLOGY; RADIOSENSITIZERS; RADIOTHERAPY
Citation Formats
Jones, Bleddyn, and Sanghera, Paul. Estimation of Radiobiologic Parameters and Equivalent Radiation Dose of Cytotoxic Chemotherapy in Malignant Glioma. United States: N. p., 2007.
Web. doi:10.1016/j.ijrobp.2006.12.025.
Jones, Bleddyn, & Sanghera, Paul. Estimation of Radiobiologic Parameters and Equivalent Radiation Dose of Cytotoxic Chemotherapy in Malignant Glioma. United States. doi:10.1016/j.ijrobp.2006.12.025.
Jones, Bleddyn, and Sanghera, Paul. Fri .
"Estimation of Radiobiologic Parameters and Equivalent Radiation Dose of Cytotoxic Chemotherapy in Malignant Glioma". United States.
doi:10.1016/j.ijrobp.2006.12.025.
@article{osti_20951663,
title = {Estimation of Radiobiologic Parameters and Equivalent Radiation Dose of Cytotoxic Chemotherapy in Malignant Glioma},
author = {Jones, Bleddyn and Sanghera, Paul},
abstractNote = {Purpose: To determine the radiobiologic parameters for highgrade gliomas. Methods and Materials: The biologic effective dose concept is used to estimate the {alpha}/{beta} ratio and K (dose equivalent for tumor repopulation/d) for highgrade glioma patients treated in a randomized fractionation trial. The equivalent radiation dose of temozolomide (Temodar) chemotherapy was estimated from another randomized study. The method assumes that the radiotherapy biologic effective dose is proportional to the adjusted radiotherapy survival duration of highgrade glioma patients. Results: The median tumor {alpha}/{beta} and K estimate is 9.32 Gy and 0.23 Gy/d, respectively. Using the published surviving fraction after 2Gy exposure (SF{sub 2}) data, and the above {alpha}/{beta} ratio, the estimated median {alpha} value was 0.077 Gy{sup 1}, {beta} was 0.009 Gy{sup 2}, and the cellular doubling time was 39.5 days. The median equivalent biologic effective dose of temozolomide was 11.03 Gy{sub 9.3} (equivalent to a radiation dose of 9.1 Gy given in 2Gy fractions). Random sampling trial simulations based on a cure threshold of 70 Gy in highgrade gliomas have shown the potential increase in tumor cure with dose escalation. Partial elimination of hypoxic cells (by chemical hypoxic cell sensitizers or carbon ion therapy) has suggested that considerable gains in tumor control, which are further supplemented by temozolomide, are achievable. Conclusion: The radiobiologic parameters for human highgrade gliomas can be estimated from clinical trials and could be used to inform future clinical trials, particularly combined modality treatments with newer forms of radiotherapy. Other incurable cancers should be studied using similar radiobiologic analysis.},
doi = {10.1016/j.ijrobp.2006.12.025},
journal = {International Journal of Radiation Oncology, Biology and Physics},
number = 2,
volume = 68,
place = {United States},
year = {Fri Jun 01 00:00:00 EDT 2007},
month = {Fri Jun 01 00:00:00 EDT 2007}
}

Purpose: To estimate a plausible set of radiobiologic parameters such as {alpha}, {alpha}/{beta} values, from clinical outcomes for biologically based radiation treatment planning of brain tumors. Methods and Materials: Linearquadratic (LQ) formalism and the concept of equivalent uniform dose were used to analyze a series of published clinical data for malignant gliomas involving different forms of radiation therapy. Results: A plausible set of LQ parameters was obtained for gliomas: {alpha} = 0.06 {+} 0.05 Gy{sup 1}, {alpha}/{beta} = 10.0 {+} 15.1 Gy, the tumor cell doubling time T{sub d} = 50 {+} 30 days, with the repair halftime of 0.5more »

Boron neutron capture therapy using mixed epithermal and thermal neutron beams in patients with malignant gliomacorrelation between radiation dose and radiation injury and clinical outcome
Purpose: To clarify the correlation between the radiation dose and clinical outcome of sodium borocaptatebased intraoperative boron neutron capture therapy in patients with malignant glioma. Methods and Materials: The first protocol (P1998, n = 8) prescribed a maximal gross tumor volume (GTV) dose of 15 Gy. In 2001, a doseescalated protocol was introduced (P2001, n 11), which prescribed a maximal vascular volume dose of 15 Gy or, alternatively, a clinical target volume (CTV) dose of 18 Gy. Results: The GTV and CTV doses in P2001 were 1.11.3 times greater than those in P1998. The maximal vascular volume dose of thosemore » 
Incidence of malignant thyroid tumors in humans after exposure to diagnostic doses of /sup 131/I. II. Estimation of thyroid gland size, thyroid radiation dose, and predicted versus observed number of malignant thyroid tumors
The size of the thyroid glands was analyzed for 10% of the patients in a selected group that had been exposed to diagnostic doses of /sup 131/I. The mean thyroid gland weight + SD was 50 + 33 g for patients 20 or more years of age and 10 + 5 g for patients less than 20 years of age. With the present followup, diagnostic doses of /sup 131/I appeared not to be associated with an increased risk for later development of malignant thyroid tumors. Possible reasons for the difference between the observed number of such tumors and the numbermore » 
Estimation of radiationinduced cancer from threedimensional dose distributions: Concept of organ equivalent dose
Purpose: Estimates of secondary cancer risk after radiotherapy are becoming more important for comparative treatment planning. Modern treatment planning systems provide accurate threedimensional dose distributions for each individual patient. These data open up new possibilities for more precise estimates of secondary cancer incidence rates in the irradiated organs. We report a new method to estimate organspecific radiationinduced cancer incidence rates. The concept of an organ equivalent dose (OED) for radiationinduced cancer assumes that any two dose distributions in an organ are equivalent if they cause the same radiationinduced cancer incidence. Methods and Materials: The two operational parameters of the OEDmore » 
Use of Concept of ChemotherapyEquivalent Biologically Effective Dose to Provide Quantitative Evaluation of Contribution of Chemotherapy to Local Tumor Control in Chemoradiotherapy Cervical Cancer Trials
Purpose: To express the magnitude of the contribution of chemotherapy to local tumor control in chemoradiotherapy cervical cancer trials in terms of the concept of the biologically effective dose. Methods and Materials: The local control rates of both arms of each study (radiotherapy vs. radiotherapy plus chemotherapy) reported from randomized controlled trials of concurrent chemoradiotherapy for cervical cancer were reviewed and expressed using the Poisson model for tumor control probability (TCP) as TCP = exp(exp E), where E is the logarithm of cell kill. By combining the two TCP values from each study, we calculated the chemotherapyrelated log cell killmore »